Methods and compositions relating to a vaccine against prostate cancer

Christoph Leder; Alan D. King; Maxim Pavlenko; Pavel Pisa

Methods and compositions relating to a vaccine against prostate cancer

Publikation: Schutzrechte › Schutzrecht

Standard

Methods and compositions relating to a vaccine against prostate cancer. / Leder, Christoph; King, Alan D.; Pavlenko, Maxim et al.
Patent Nr.: WO/2007/002149 A2. Jan. 04, 2007.

Publikation: Schutzrechte › Schutzrecht

Harvard

Leder, C, King, AD, Pavlenko, M & Pisa, P Jan.. 04 2007, Methods and compositions relating to a vaccine against prostate cancer, Patent Nr. WO/2007/002149 A2.

APA

Leder, C., King, A. D., Pavlenko, M., & Pisa, P. (2007). Methods and compositions relating to a vaccine against prostate cancer. (Patent Nr. WO/2007/002149 A2).

Vancouver

Leder C, King AD, Pavlenko M, Pisa P. Methods and compositions relating to a vaccine against prostate cancer. WO/2007/002149 A2. 2007 Jan 4.

Bibtex

@misc{48741bcdee034bea8929db63b631cef7,

title = "Methods and compositions relating to a vaccine against prostate cancer",

abstract = "An object of the invention is to provide methods and compositions relating to a vaccine against prostate cancer which includes a non- human -primate PSA for administration to humans to provide an immune response against human PSA. More generally, an object of the invention is to provide methods and compositions relating to using a non-human primate xenogeneic antigen (e. g. protein) in a human, wherein, with respect to the non-human primate xenogeneic antigen that is used, there are relatively few interspecies differences between the non-human primate xenogeneic antigen and the human self antigen in order to induce an optimal immune response in the human to its native self antigen.",

keywords = "Chemistry",

author = "Christoph Leder and King, {Alan D.} and Maxim Pavlenko and Pavel Pisa",

note = "Anmeldenummer PCT/US2006/0204076; WO/2007/002149 A2; A61K39/00 (2006.01)",

year = "2007",

month = jan,

day = "4",

language = "English",

type = "Patent",

}

RIS

TY - PAT

T1 - Methods and compositions relating to a vaccine against prostate cancer

AU - Leder, Christoph

AU - King, Alan D.

AU - Pavlenko, Maxim

AU - Pisa, Pavel

N1 - Anmeldenummer PCT/US2006/0204076

PY - 2007/1/4

Y1 - 2007/1/4

N2 - An object of the invention is to provide methods and compositions relating to a vaccine against prostate cancer which includes a non- human -primate PSA for administration to humans to provide an immune response against human PSA. More generally, an object of the invention is to provide methods and compositions relating to using a non-human primate xenogeneic antigen (e. g. protein) in a human, wherein, with respect to the non-human primate xenogeneic antigen that is used, there are relatively few interspecies differences between the non-human primate xenogeneic antigen and the human self antigen in order to induce an optimal immune response in the human to its native self antigen.

AB - An object of the invention is to provide methods and compositions relating to a vaccine against prostate cancer which includes a non- human -primate PSA for administration to humans to provide an immune response against human PSA. More generally, an object of the invention is to provide methods and compositions relating to using a non-human primate xenogeneic antigen (e. g. protein) in a human, wherein, with respect to the non-human primate xenogeneic antigen that is used, there are relatively few interspecies differences between the non-human primate xenogeneic antigen and the human self antigen in order to induce an optimal immune response in the human to its native self antigen.

KW - Chemistry

M3 - Patent

M1 - WO/2007/002149 A2

Y2 - 2006/06/21

ER -